The heart rate variability-derived Newborn Infant Parasympathetic Evaluation (NIPE (TM)) Index in pediatric surgical patients from 0 to 2 years under sevoflurane anesthesia by Weber, F. (Frank) et al.
Pediatric Anesthesia. 2019;29:377–384.	 	 	 | 	377wileyonlinelibrary.com/journal/pan
 
Received:	22	October	2018  |  Revised:	5	February	2019  |  Accepted:	13	February	2019
DOI: 10.1111/pan.13613  
R E S E A R C H  R E P O R T
The heart rate variability‐derived Newborn Infant 
Parasympathetic Evaluation (NIPE™) Index in pediatric surgical 
patients from 0 to 2 years under sevoflurane anesthesia—A 
prospective observational pilot study
Frank Weber  |   Hilde G. Roeleveld |   Noortje J. E. Geerts |   Annejet T. Warmenhoven |   
































resulted	 in	 a	 rise	 of	 NIPE	 values,	 reaching	 a	 maximum	 increase	 of	 5.1	 (95%	 CI:	
0.22‐9.99)	units	120	seconds	after	drug	administration	(P	=	0.041).	There	was	no	evi‐
dence	of	a	change	in	heart	rate	during	these	two	120	seconds	periods.	Per	protocol	
administration	 of	 morphine,	 caudal	 block,	 and	 surgical	 incision	 did	 not	 result	 in	
changes	of	the	NIPE,	which	was	around	65	units	on	these	occasions,	and	heart	rate.
Conclusion: In	 infants	 anesthetized	 with	 sevoflurane,	 NIPE	 values	 <50	 might	 be	
indicative	of	insufficient	antinociception.	The	results	of	this	observational	pilot	study	
might	suggest	that	the	NIPE	could	be	a	better	measure	of	the	nociception/antinocic‐
eption balance than heart rate.






known	to	have	 low	sensitivity	and	specificity	 in	detecting	 inade‐
quate	 antinociception,	 possibly	 resulting	 in	 under‐	 or	 overdosing	
of	opioid	drugs.1	 The	 clinical	 impression	of	 an	 anesthetist	 surely	
remains	 the	 most	 frequently	 applied	 heuristic	 approach	 to	 help	
decide	whether	 or	 not	 an	 anesthetized	 patient	 needs	 additional	
opioids.
Several	 analgesia	monitoring	 systems,	 aiming	 to	achieve	con‐
tinuous,	 objective,	 and	 nondisruptive	 detection	 of	 analgesia	 or	
assessment	 of	 the	 nociception/antinociception	 balance	 have	 re‐
cently	become	commercially	available.	These	devices	use	surrogate	
parameters	 of	 nociception,	 such	 as	 processed	 skin	 conductance,	
plethysmography,	 pupillometry,	 and	 heart	 rate	 variability	 (HRV)	
analysis.2
Recent	 studies	 performed	 in	 anesthetized	 children	 sug‐
gest	 that	 the	 heart	 rate	 variability	 analysis	 derived	 Analgesia	
Nociception	 Index	 (ANI™;	 Mdoloris	 Medical	 Systems,	 Loos,	
France)	may	provide	a	more	sensitive	assessment	of	the	nocicep‐





older	 than	2	years.	Neonates	 and	 infants	 (<2	years),	 due	 to	 imma‐
turity	of	the	autonomous	nervous	system	and	a	higher	baseline	HR	
resulting	in	a	lower	possible	variability,	require	a	modified	approach	





regarding	 the	 nociception/antinociception	 balance	 in	 anesthetized	
children,	little	is	known	about	the	performance	of	the	NIPE	in	anes‐
thetized	neonates	and	infants.
The	 primary	 objective	 of	 this	 prospective	 observational	
pilot	study	 in	surgical	neonates	and	 infants	under	sevoflurane	
anesthesia,	was	to	investigate	the	ability	of	the	NIPE	and	heart	
rate	 to	 detect	 an	 insufficient	 antinociception.	 Major	 second‐
ary	objectives	were	 the	 impact	 of	 per	 protocol	 opioid	 admin‐
istration	for	postoperative	analgesia,	caudal	analgesia,	and	the	
surgical	 incision	 on	 the	 course	 of	 the	NIPE.	 Changes	 in	NIPE	
values	were	compared	to	concomitant	changes	in	heart	rate	for	
all	analyses.
2  | MATERIAL S AND METHODS
2.1 | Patient selection
This	 single	 center	 prospective	 observational	 pilot	 study	 was	 ap‐
proved	by	the	Medical	Ethics	Committee	of	the	Erasmus	University	
Medical	 Center,	 Rotterdam,	 The	 Netherlands	 (MEC‐2016‐501;	
August	 9,	 2016)	 and	 was	 conducted	 in	 accordance	 with	 the	
Declaration	of	the	World	Medical	Association.	The	written	informed	
consent	was	obtained	 for	 all	 participating	patients	 from	 their	 par‐
ents	or	 legal	 representatives.	The	study	was	conducted	 in	accord‐
ance	with	the	STROBE	guidelines10	between	March	and	June	2017.
Pediatric	 patients	 aged	0‐2	years,	 scheduled	 for	 surgical	 or	 di‐
agnostic	 procedures	 under	 sevoflurane	 anesthesia,	 performed	 at	
the	Erasmus	University	Medical	Center—Sophia	Children's	Hospital,	
Rotterdam,	The	Netherlands,	were	eligible	for	inclusion.	According	
to	 departmental	 standards	 patients	 received	 intravenous	 parac‐
etamol	20	mg/kg	and	diclofenac	1	mg/kg	 (only	 infants	>6	months)	
during	the	procedure	for	postoperative	analgesia.	Depending	on	the	
surgical	 procedure	 patients	 furthermore	 received	 either	 a	 caudal	
block	(ropivacaine	0.2%,	1‐1.25	mL/kg)	or	iv	morphine	(0.1	mg/kg).
Due	 to	 technical	 requirements	 of	 the	NIPE	 algorithm	 any	 car‐
diac	 rhythm	other	 than	 sinus	 rhythm,	presence	of	 an	 internal	 car‐
diac	pacemaker,	high‐frequency	oscillation‐	or	jet‐ventilation	during	
surgery,	and	chronic	use	of	medication	interfering	with	the	cardiac	
rhythm	were	 defined	 as	 primary	 exclusion	 criteria.	 Intraoperative	
need	for	clonidine,	atropine	or	inotropes,	and	vasopressors	resulted	
in	secondary	exclusion.
2.2 | The Newborn Infant Parasympathetic 
Evaluation Index
The	heart	rate	variability‐derived	Newborn	Infant	Parasympathetic	
Evaluation	 Index	 (NIPE)	 is	 calculated	 by	 using	 the	 ECG	 signal	
K E Y W O R D S
general	anesthesia,	infant,	monitors,	pain
What is already known
•	 Processed	heart	rate	variability	is	a	sensitive	measure	of	
insufficient	 antinociception	 in	 anesthetized	 adult	 pa‐
tients	 and	 children	>2	years.	Data	 regarding	 its	 perfor‐
mance	in	anesthetized	neonates	and	infants	are	lacking.
What this article adds
•	 The	 heart	 rate	 variability‐derived	 Newborn	 Infant	
Parasympathetic	 Evaluation	 (NIPE™)	 Index	might	 be	 a	
more	 reliable	measure	of	 the	nociception/antinocicep‐
tion	balance	in	anesthetized	infants	than	heart	rate.
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2.3 | Intraoperative collection of study data
NIPE‐	 and	 heart	 rate	 data,	 recorded	 during	 the	 anesthetic,	 were	
downloaded	from	the	NIPE‐monitor	as	.txt‐files.	Data	derived	from	
our	Dräger	Infinity	patient	monitoring	system	were	exported	as	.xls	








Analyses	were	 performed	 using	 data	 timely	 related	 to	 predefined	
events.	An	event	was	defined	as	 the	 intraoperative	administration	
of	opioid	drugs,	either	due	to	the	clinical	judgement	of	insufficient	
antinociception	 or	 per‐protocol	 administration	 for	 postoperative	
analgesia.




ment	 of	 insufficient	 antinociception	 and	 after	 subsequent	 opioid	


















based	on	our	 average	annual	number	of	 anesthetics	performed	 in	
children	younger	 than	2	years,	 should	be	sufficient	 to	 include	≥50	
participants.
Data	analysis	was	performed	using	Prism	7	for	Mac	OS	X	(Version	
7.0e,	GraphPad	Software	 Inc,	 La	 Jolla,	CA).	Continuous	data	were	
presented	as	mean	(SD).	P	values	<0.05	were	considered	significant.
3  | RESULTS
3.1 | Participant demographics and general patient 
information
A	 total	 of	 74	patients	 (female/male:	 20/54)	was	 recruited	 for	 par‐
ticipation,	of	which	7	patients	had	to	be	excluded	from	data	analysis	
due	 to	 the	permanent	data	 logging	 failure.	Age	and	weight	of	 the	
remaining	67	patients	were	36.7	±	21.5	weeks	 (postnatal	 age)	 and	
8.03	±	2.34	kg,	respectively.	Information	regarding	the	surgical	pro‐
cedures	and	anesthesia	techniques	are	given	in	Table	1.








Ear	nose	&	throat	surgery 3  
Ophthalmological	surgery 5  
General	pediatric	surgery 8 10
Neurosurgery 15  
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A	 total	 of	 54	 events	 (intraoperative	 opioid	 drug	 administra‐
tion)	 was	 recorded,	 of	 which	 14	 had	 to	 be	 excluded	 from	 anal‐









3.2 | Course of NIPE and HR values around 
opioid administration due to perceived insufficient 
antinociception
Data	from	10	events	recorded	in	patients	with	NIPE	values	<50	at	
the	 time	 of	 decision	 (DecisionNIPE	 <50),	were	 available	 for	 analysis.	
RM‐ANOVA	 revealed	 no	 evidence	 of	 a	 difference	 between	NIPE‐
values	at	the	time	of	decision	to	give	opioid	drugs	due	to	a	perceived	







onds	 after	 drug	 administration	 (fentanyl	 1.6	±	0.6	µg/kg	 [n	=	25],	


















F I G U R E  1  Course	of	the	Newborn	Infant	Parasympathetic	Evaluation	Index	(NIPE)	and	heart	rate	(HR)	before	and	after	iv	opioid	
drug	administration	associated	with	NIPE‐values	<50	(n	=	10)	and	≥	50	(n	=	30)	at	the	moment	of	decision	to	administer	opioids.	Data	are	
presented	as	mean	±	SD	[Colour	figure	can	be	viewed	at	wileyonlinelibrary.com]
P = P = P =
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3.3 | Course of NIPE and HR values around per 
protocol application of morphine
Data	from	nine	events	were	available	for	analysis.	RM‐ANOVA	re‐
vealed	no	evidence	of	 a	 difference	 in	NIPE	 and	HR	values	within	
both	120	seconds	windows	prior	to	decision	to	give	morphine	(NIPE:	
P	=	0.573;	HR:	P	=	0.709)	and	300	seconds	after	administration	of	
0.1	µg/kg	 morphine	 (NIPE:	 P	=	0.170;	 HR:	 P	=	0.183).	 The	 lowest	
and	highest	NIPE	values	after	morphine	application	were	55	±	12.4	
and	65	±	12.3,	respectively.	For	details	see	Figure	2	and	Table	2.
3.4 | Course of NIPE and HR values in patients with 
supplemental caudal block
Data	 from	 21	 patients	 were	 available	 for	 analysis.	 RM‐ANOVA	
revealed	 no	 evidence	 of	 a	 difference	 in	 NIPE	 and	 HR	 values	 in	




Decision	vs	−120	s −8.1 −18.88	to	2.68 0.154
Decision	vs	−90	s −0.5 −13.02	to	12.02 0.999
Decision	vs	−60	s −5.8 −13.91	to	2.31 0.181
Decision	vs	−30	s −3.2 −7.23	to	0.82 0.127
Intervention	vs	+	30	s −1.1 −2.94	to	0.74 0.295
Intervention	vs	+	60	s −2.7 −2.94	to	0.75 0.051
Intervention	vs	+	90	s −3.6 −6.71	to	−0.49 0.025
Intervention	vs	+	120	s −5.1 −9.99	to	−0.22 0.041
NIPE	≥50	at	time	of	decision	(n	=	30)	[see	Figure	1]		  
Decision	vs	−120	s −4.1 −9.01	to	0.81 0.123
Decision	vs	−90	s −2.4 −6.86	to	2.06 0.451
Decision	vs	−60	s −1.3 −4.69	to	2.09 0.719
Decision	vs	−30	s −0.6 −3.85	to	2.72 0.976
Intervention	vs	+	30	s 1.6 −0.78	to	3.92 0.271
Intervention	vs	+	60	s 4.7 −1.09	to	10.56 0.137
Intervention	vs	+	90	s 4.2 −0.75	to	9.22 0.114
Intervention	vs	+	120	s 2.0 −3.44	to	7.37 0.753
NIPE	around	per	protocol	administration	of	morphine	(n	=	9)	[see	Figure	2]			
Intervention	vs	+	60	s 5.0 −8.1	to	18.1 0.656
Intervention	vs	+	120	s 3.8 −7.27	to	14.82 0.733
Intervention	vs	+	180	s 11.4 −1.78	to	24.67 0.092
Intervention	vs	+	240	s 3.9 −8.19	to	15.97 0.770
Intervention	vs	+	300	s 0.8 −11.57	to	13.13 0.10
NIPE	around	caudal	block	(n	=	21)	[see	Figure	3]	   
−30	sec	vs	block −0.3 −3.1	to	2.44 0.980
−30	sec	vs	block	+	30	s 3.6 −2.45	to	9.59 0.327
−30	sec	vs	block	+	60	s 3.8 −2.04	to	9.66 0.260
−30	sec	vs	Incision −1.5 −4.47	to	1.52 0.541
−30	sec	vs	Inc	+30	s 2.2 −3.12	to	7.56 0.681
−30	sec	vs	Inc	+60	s 4.1 −1.5	to	9.73 0.208
−30	sec	vs	Inc	+90	s 4.2 −2.23	to	10.61 0.291
−30	sec	vs	Inc	+120	s 4.67 −3.12	to	12.51 0.371
NIPE	around	surgical	incision	(n	=	35)    
−10	sec	vs	Incision 0.3 −0.93	to	1.61 0.895
−10	sec	vs	Inc	+10	s 0.8 −1.21	to	2.86 0.684
−10	sec	vs	Inc	+20	s 0.8 −1.28	to	2.82 0.738
−10	sec	vs	Inc	+30	s 1.49 −1.21	to	4.18 0.431
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response	to	the	application	of	the	caudal	block	(NIPE:	P	=	0.11;	HR:	
P	=	0.665)	and	surgical	incision,	which	was	allowed	after	a	minimum	
of	 10	min	 after	 caudal	 block	 (NIPE:	 P	=	0.05;	 HR:	 P	=	0.941);	 the	
lowest	and	highest	NIPE	values	within	this	dataset	were	65.4	±	17.4	
and	71.1	±	13.7,	respectively.	For	details	see	Figure	3	and	Table	2.
3.5 | Course of NIPE and HR values around 
surgical incision
Data	 from	 35	 patients	 (no	 supplemental	 regional	 anesthesia)	 were	
available	for	analysis.	RM‐ANOVA	revealed	no	evidence	of	a	difference	





2	years,	 anesthetized	 with	 sevoflurane,	 allow	 us	 to	 provisionally	
suggest	 the	 ability	 of	 the	NIPE	 to	 detect	 insufficient	 antinocicep‐
tion.	 This	 provisional	 conclusion	 is	 derived	 from	 the	 course	 of	 10	
events,	where	NIPE	values	<50	at	 the	 time	of	opioid	drug	 admin‐
istration	developed	positively	within	120	seconds	(see	Table	2	and	
Figure	1)	and	of	another	30	events,	where	NIPE	values	≥50	remained	
















The	NIPE‐50‐threshold	 is	 an	 extrapolation	of	 the	50	units	 thresh‐
old	recommended	when	using	the	“adult	version”	of	the	device,	the	
Analgesia	Nociception	Index	(ANI),	with	a	growing	body	of	evidence	
suggesting	 sufficient	 antinociception	 associated	 with	 ANI	 values	
≥50,	while	values	<50	are	indicative	of	insufficient	antinociception.1 












TA B L E  3  Wilcoxon	matched−pairs	signed	rank	test	comparing	
NIPE/Heart	rate	values	before	and	after	opioid	drug	application
 Median Diff. 95% CI of diff. P value
NIPE	<50	before	decision	(n	=	16)   
NIPE 11 6 to 22 <	0.001
Heart	rate 0 −3	to	2 0.692
NIPE	≥50	before	decision	(n	=	26)	   
NIPE −2.5 −17	to	6 0.167
Heart	rate −1.5 −4	to	0 0.094
























The	NIPE	was	 originally	 developed	 as	 an	 adaption	 of	 the	ANI	
technology	for	the	clinical	contexts	of	pain	monitoring	in	neonates	




















regarding	 the	 applicability	 of	 HRV‐derived	 devices	 as	 monitors	 of	
the	nociception/antinociception	balance	in	anesthetized	patients.	In	
accordance	with	 the	current	 scientific	 literature	we	assume	 that	 in	




on	 the	 NIPE	 in	 surgical	 neonates	 and	 infants.	 Unfortunately,	 the	
aforementioned	assumption	has	never	been	proven	and	we	have	no	
idea	how	this	goal	could	ever	formally	be	reached.
Sevoflurane	 effect	 on	 baroreceptor	 reflex	 might	 be	 an	 issue	
when	using	HRV	derived	 technology	under	 anesthesia	 conditions.	
A	clinical	study	performed	in	adult	patients	showed	that	sevoflurane	
attenuates	 the	 baroreceptor	 reflex,	 which	 is	 known	 to	 contribute	

















































The	 results	of	 this	observational	 study	allow	 the	 following	careful	
first	 conclusions	 regarding	 the	 performance	 of	 the	 NIPE	 in	 term‐
neonates	 and	 infants	 anesthetized	 with	 sevoflurane:	 NIPE	 values	
<50	 might	 be	 indicative	 of	 insufficient	 antinociception.	 Whether	
or	 not	 an	 average	 rise	 of	 5	 NIPE	 units	 within	 120	seconds	 after	
opioid	 drug	 administration	 reflects	 re‐establishment	 of	 sufficient	
antinociception	remains	unclear.	A	rise	 in	NIPE	values	after	opioid	
drug	 administration	 is	 not	 necessarily	 associated	 with	 changes	 in	
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